Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Digestive Care
Digestive Care
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pertzye
Pancrelipase
2012-05-17
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pancrelipase
short bowel syndrome
,
exocrine pancreatic insufficiency
,
chronic pancreatitis
,
cystic fibrosis
,
pancreatic neoplasms
Aspartame
lymphoma
,
conjunctivitis
,
allergic rhinitis
,
rhinitis
,
allergic conjunctivitis
,
liver neoplasms
,
atopic dermatitis
,
dermatitis
,
neoplasm metastasis
,
healthy volunteers/patients
,
neoplasms
,
prostatic neoplasms
,
vomiting
,
nausea
,
infections
,
esophageal neoplasms
,
postoperative nausea and vomiting
,
brain neoplasms
,
second primary neoplasms
,
depression
,
treatment-resistant depressive disorder
,
depressive disorder
,
esophageal squamous cell carcinoma
,
hematologic neoplasms
,
pneumonia
,
pseudomonas infections
,
pseudomonas aeruginosa
,
bacteremia
,
renal cell carcinoma
,
liver cirrhosis
,
experimental liver cirrhosis
,
chronic obstructive pulmonary disease
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
recurrence
,
melanoma
,
colorectal neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
non-muscle invasive bladder neoplasms
,
non-small-cell lung carcinoma
,
hiv infections
,
carcinoma
,
acquired immunodeficiency syndrome
,
lung neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
triple negative breast neoplasms
,
breast neoplasms
,
condylomata acuminata
,
fibrosis
,
hepatocellular carcinoma
,
hiv-2
,
immunologic deficiency syndromes
,
hiv-1
,
antibiotic prophylaxis
,
hepatitis b
,
chronic hepatitis b
,
ovarian epithelial carcinoma
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
lung diseases
,
cystic fibrosis
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
endometrial neoplasms
,
fallopian tube neoplasms
,
asthma
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
hepatitis c
,
hiv
,
neuromuscular blockade
,
chronic kidney failure
,
kidney diseases
,
chronic hepatitis
,
intestinal diseases
,
hypertension
,
non-hodgkin lymphoma
,
infertility
,
schizophrenia
,
traumatic brain injuries
,
brain concussion
,
brain injuries
,
post-concussion syndrome
,
papillomavirus infections
,
uterine cervical dysplasia
Nadide
healthy volunteers/patients
,
type 2 diabetes mellitus
,
diabetes mellitus
,
covid-19
,
type 1 diabetes mellitus
,
rheumatoid arthritis
,
arthritis
,
pharmacokinetics
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
coronavirus infections
,
breast neoplasms
,
obesity
,
neoplasms
,
colorectal neoplasms
,
neoplasm metastasis
,
hematologic neoplasms
,
renal cell carcinoma
,
castration-resistant prostatic neoplasms
,
urologic neoplasms
,
pancreatic neoplasms
,
endometrial neoplasms
,
transitional cell carcinoma
,
pancreatic ductal carcinoma
,
stomach neoplasms
,
biliary tract neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use